N-Acetyl Cysteine showed improved dopamine transporter binding in a 42-patient Parkinson’s study. It’s the strongest evidence in our research — but it has major limitations.
The methodology behind our research packages is elemental pattern matching — not drug discovery. Here’s exactly what it does, how it works, and why the distinction matters.